Retention of functional DC-NK cross-talk following up to 18 weeks therapy interruptions in chronically suppressed HIV type 1+ subjects.
Papasavvas
Emmanouil
E
Chehimi
Jihed
J
Azzoni
Livio
L
Pistilli
Maxwell
M
Thiel
Brian
B
Mackiewicz
Agnieszka
A
Creer
Shenoa
S
Mounzer
Karam
K
Kostman
Jay R
JR
Montaner
Luis J
LJ
D018791:CD4 Lymphocyte Count; D003713:Dendritic Cells / Q000276:immunology*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000097:blood / Q000276:immunology / Q000628:therapy*; D015497:HIV-1 / Q000472:pathogenicity* / Q000502:physiology; D006801:Humans; D007694:Killer Cells, Natural / Q000276:immunology*; D014779:Virus Replication